Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma:A Report from the International DLBCL Rituximab-CHOP Consortium Program

Authors
Publication date
1 January 2014
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    VBN

    redirect
    oaioai:pure.atira.dk:publications...
    Last time updated on 17/11/2016